Literature DB >> 34470781

Patient-Derived Xenografts to Study Cancer Metabolism: When Does X Mark the Spot?

Christopher S Nabel1,2, Matthew G Vander Heiden3,4,5.   

Abstract

A major goal of cancer research is to understand the requirements for cancer growth and progression that can be exploited to treat patients. Model systems reduce the complexity and heterogeneity of human cancers to explore therapeutic hypotheses, however, some relevant aspects of human biology are not well represented by certain models, complicating the translation of preclinical findings to help patients. Here we discuss the advantages and limitations of patient-derived xenografts as a model system to study cancer metabolism, offering a framework to best use these models to address different types of metabolism-specific research questions. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 34470781      PMCID: PMC8425604          DOI: 10.1158/0008-5472.CAN-21-0770

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

Review 1.  Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.

Authors:  Jackie E Bader; Kelsey Voss; Jeffrey C Rathmell
Journal:  Mol Cell       Date:  2020-06-18       Impact factor: 17.970

2.  MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion.

Authors:  Milind D Chalishazar; Sarah J Wait; Fang Huang; Abbie S Ireland; Anandaroop Mukhopadhyay; Younjee Lee; Sophia S Schuman; Matthew R Guthrie; Kristofer C Berrett; Jeffery M Vahrenkamp; Zeping Hu; Marek Kudla; Katarzyna Modzelewska; Guoying Wang; Nicholas T Ingolia; Jason Gertz; David H Lum; Sabina C Cosulich; John S Bomalaski; Ralph J DeBerardinis; Trudy G Oliver
Journal:  Clin Cancer Res       Date:  2019-06-04       Impact factor: 12.531

3.  Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer.

Authors:  Anna F Farago; Beow Y Yeap; Marcello Stanzione; Yin P Hung; Rebecca S Heist; J Paul Marcoux; Jun Zhong; Deepa Rangachari; David A Barbie; Sarah Phat; David T Myers; Robert Morris; Marina Kem; Taronish D Dubash; Elizabeth A Kennedy; Subba R Digumarthy; Lecia V Sequist; Aaron N Hata; Shyamala Maheswaran; Daniel A Haber; Michael S Lawrence; Alice T Shaw; Mari Mino-Kenudson; Nicholas J Dyson; Benjamin J Drapkin
Journal:  Cancer Discov       Date:  2019-08-15       Impact factor: 39.397

4.  Neurons Release Serine to Support mRNA Translation in Pancreatic Cancer.

Authors:  Robert S Banh; Douglas E Biancur; Keisuke Yamamoto; Albert S W Sohn; Beth Walters; Miljan Kuljanin; Ajami Gikandi; Huamin Wang; Joseph D Mancias; Robert J Schneider; Michael E Pacold; Alec C Kimmelman
Journal:  Cell       Date:  2020-11-02       Impact factor: 41.582

5.  Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer.

Authors:  C Allison Stewart; Carl M Gay; Yuanxin Xi; Santhosh Sivajothi; V Sivakamasundari; Junya Fujimoto; Mohan Bolisetty; Patrice M Hartsfield; Veerakumar Balasubramaniyan; Milind D Chalishazar; Cesar Moran; Neda Kalhor; John Stewart; Hai Tran; Stephen G Swisher; Jack A Roth; Jianjun Zhang; John de Groot; Bonnie Glisson; Trudy G Oliver; John V Heymach; Ignacio Wistuba; Paul Robson; Jing Wang; Lauren Averett Byers
Journal:  Nat Cancer       Date:  2020-02-17

6.  Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities.

Authors:  Carl M Gay; C Allison Stewart; Elizabeth M Park; Lixia Diao; Sarah M Groves; Simon Heeke; Barzin Y Nabet; Junya Fujimoto; Luisa M Solis; Wei Lu; Yuanxin Xi; Robert J Cardnell; Qi Wang; Giulia Fabbri; Kasey R Cargill; Natalie I Vokes; Kavya Ramkumar; Bingnan Zhang; Carminia M Della Corte; Paul Robson; Stephen G Swisher; Jack A Roth; Bonnie S Glisson; David S Shames; Ignacio I Wistuba; Jing Wang; Vito Quaranta; John Minna; John V Heymach; Lauren Averett Byers
Journal:  Cancer Cell       Date:  2021-01-21       Impact factor: 31.743

7.  Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition.

Authors:  Alexander Muir; Laura V Danai; Dan Y Gui; Chiara Y Waingarten; Caroline A Lewis; Matthew G Vander Heiden
Journal:  Elife       Date:  2017-08-15       Impact factor: 8.140

8.  Metabolic heterogeneity confers differences in melanoma metastatic potential.

Authors:  Alpaslan Tasdogan; Brandon Faubert; Vijayashree Ramesh; Jessalyn M Ubellacker; Bo Shen; Ashley Solmonson; Malea M Murphy; Zhimin Gu; Wen Gu; Misty Martin; Stacy Y Kasitinon; Travis Vandergriff; Thomas P Mathews; Zhiyu Zhao; Dirk Schadendorf; Ralph J DeBerardinis; Sean J Morrison
Journal:  Nature       Date:  2019-12-18       Impact factor: 49.962

9.  Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts.

Authors:  Xing Yi Woo; Jessica Giordano; Anuj Srivastava; Zi-Ming Zhao; Michael W Lloyd; Roebi de Bruijn; Yun-Suhk Suh; Rajesh Patidar; Li Chen; Sandra Scherer; Matthew H Bailey; Chieh-Hsiang Yang; Emilio Cortes-Sanchez; Yuanxin Xi; Jing Wang; Jayamanna Wickramasinghe; Andrew V Kossenkov; Vito W Rebecca; Hua Sun; R Jay Mashl; Sherri R Davies; Ryan Jeon; Christian Frech; Jelena Randjelovic; Jacqueline Rosains; Francesco Galimi; Andrea Bertotti; Adam Lafferty; Alice C O'Farrell; Elodie Modave; Diether Lambrechts; Petra Ter Brugge; Violeta Serra; Elisabetta Marangoni; Rania El Botty; Hyunsoo Kim; Jong-Il Kim; Han-Kwang Yang; Charles Lee; Dennis A Dean; Brandi Davis-Dusenbery; Yvonne A Evrard; James H Doroshow; Alana L Welm; Bryan E Welm; Michael T Lewis; Bingliang Fang; Jack A Roth; Funda Meric-Bernstam; Meenhard Herlyn; Michael A Davies; Li Ding; Shunqiang Li; Ramaswamy Govindan; Claudio Isella; Jeffrey A Moscow; Livio Trusolino; Annette T Byrne; Jos Jonkers; Carol J Bult; Enzo Medico; Jeffrey H Chuang
Journal:  Nat Genet       Date:  2021-01-07       Impact factor: 38.330

10.  Patient-derived xenografts undergo mouse-specific tumor evolution.

Authors:  Uri Ben-David; Gavin Ha; Yuen-Yi Tseng; Noah F Greenwald; Coyin Oh; Juliann Shih; James M McFarland; Bang Wong; Jesse S Boehm; Rameen Beroukhim; Todd R Golub
Journal:  Nat Genet       Date:  2017-10-09       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.